novispirin T-7

General Information


DRACP ID  DRACP00021

Peptide Name   novispirin T-7

Sequence  KNLRRITRKIIHIIKKYG

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
ME-180 Human papillomavirus-related cervical squamous cell carcinoma; Squamous cell carcinoma of the cervix uteri Carcinoma 81.5% Cytotoxicity=200 µg/ml MTT assay 20h 1
A549 Lung adenocarcinoma Carcinoma 81.5% Cytotoxicity=200 µg/ml MTT assay 20h 1

Hemolytic Activity  Human erythrocytes: 10% Hemolysis=80 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00021

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C103H184N34O22

Absent amino acids  ACDEFMPQSVW

Common amino acids  I

Mass  255422

Pl  12.28

Basic residues  8

Acidic residues  0

Hydrophobic residues  6

Net charge  8

Boman Index  -5051

Hydrophobicity  -66.11

Aliphatic Index  130

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  87.65

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 11932493

Title  Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides

Doi 10.1093/protein/15.3.225

Year  2002

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_697

DRACP is developed by Dr.Zheng's team.